Cancer and Hematology Centers of Western Michigan ( Site 2222) — Grand Rapids, Michigan

Cancer and Hematology Centers of Western Michigan ( Site 2222) is a clinical research site located in Grand Rapids, Michigan, United States 49503.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer and Hematology Centers of Western Michigan ( Site 2222) has participated in 1 clinical trials.

Therapeutic areas: Hodgkin Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer and Hematology Centers of Western Michigan ( Site 2222)?

Cancer and Hematology Centers of Western Michigan ( Site 2222) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer and Hematology Centers of Western Michigan ( Site 2222) conducted?

Cancer and Hematology Centers of Western Michigan ( Site 2222) has 1 clinical trials on record. Their work covers Hodgkin Lymphoma.

Is Cancer and Hematology Centers of Western Michigan ( Site 2222) accredited by Crixeo Health?

Cancer and Hematology Centers of Western Michigan ( Site 2222) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer and Hematology Centers of Western Michigan ( Site 2222)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.